Andrea Guytingco, MPH, CIH, Takeda Pharmaceutical Company Limited - Qepler Summits And Conferences

Andrea Guytingco, MPH, CIH

Sr. EHS Business Partner
Takeda Pharmaceutical Company Limited
Takeda is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients.

Related Sessions:

3rd Annual Highly Potent
APIs Summit 2023

Assess and reduce manufacturing and handling challenges for highly potent active pharmaceutical ingredients.
  • 22 Feb 2023
  • Virtual,
  • Pharma
Day 2: Thursday, 23 February 2023
CASE STUDY: Exposure Assessment Challenges for New Modality Potent Compounds in R&D

As the shift in the pharmaceutical R&D environment goes from small molecule, solid, powder handling transitions to large molecule, liquid handling, how does Industrial Hygiene and the greater EHS team adapt to new methods of risk assessment and control? This presentations addresses:

  • The partnership of Industrial Hygiene and Biosafety practices to mitigate employee exposure to pharmaceutical ingredients that have both biological and chemical components or require additional employee protection.
  • Understanding that traditional Industrial Hygiene risk assessments can be difficult when there is limited knowledge or data on the API being handed. How do we make our best educated recommendation on controls that’s not overly conservative?
  • Designing spaces for adaptability and flexibility.
  • Case studies highlighting the challenges of controlling for new modality potent compounds in an R&D setting.
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.